Bicycle Therapeutics plc
Bicycle Therapeutics plc (BCYC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCYC · as of Jun 8, 2026
Key Statistics
Explore Bicycle Therapeutics plc Data
bcyc stock data · financialsAbout Bicycle Therapeutics plc
Bicycle Therapeutics plc a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a …
what is bicycle therapeutics plc · bcyc stock overview · bicycle therapeutics plc company profile · who is bicycle therapeutics plc ceo · bcyc NASDAQ · bicycle therapeutics plc headquarters · bicycle therapeutics plc business segments
About Stock Overview & Key Data
Bicycle Therapeutics plc (BCYC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 23, 2019. As of the latest trading session, BCYC stock price is $4.20, with a market capitalization of $291.5M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Bicycle Therapeutics plc (BCYC) stock price is $4.20. The stock is traded on NASDAQ under the ticker symbol BCYC. The 52-week range is $4.08 – $9.36.